4d Molecular Therapeutics, Inc. · NASDAQ:FDMT
Kirn David sold 1,922 4d Molecular Therapeutics, Inc. shares (Form 4)
Traded Jun 1, 2026 · Filed Jun 2, 2026
On Jun 1, 2026, Kirn David (Director, See Remarks) sold 1,922 4d Molecular Therapeutics, Inc. shares at US$10.02 for US$19,258 under a trading plan, leaving 1,057,231 shares. Filed Jun 2, 2026 (Form 4).
- Sold
- 1,922 shares
- Price
- US$10.02
- Value
- US$19,258
- Holding after
- 1,057,231 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, See Remarks
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | Common Stock | Sale | 1,922 | US$10.02 | 1,057,231 | Direct |
Source
Related
- 4d Molecular Therapeutics, Inc.
- Kirn David
- 4d Molecular Therapeutics, Inc. shareholders
- Form 4 · Kirn David · Oct 7, 2026
- Form 4 · Kirn David · Sep 16, 2026
- Form 4 · Kirn David · Aug 21, 2026
- Form 4 · Kirn David · Aug 5, 2026
- Form 4 · Kirn David · Aug 4, 2026
- Form 4 · Bizily Scott · Oct 20, 2026
- Form 4 · Bizily Scott · Sep 22, 2026
- Form 4 · Bizily Scott · Sep 3, 2026
- Form 4 · Bizily Scott · Aug 17, 2026
- Form 4 · Kirn David · Jul 14, 2026